BioLife Solutions Sees Prelim FY23 Revenue $143.3M Vs $144.37M Est.
Portfolio Pulse from Benzinga Newsdesk
BioLife Solutions announced preliminary FY23 revenue of $143.3 million, which is slightly below the estimated $144.37 million.
January 08, 2024 | 1:20 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
BioLife Solutions' preliminary FY23 revenue falls short of analysts' expectations by approximately $1.07 million.
Missing revenue estimates, even by a small margin, can lead to negative investor sentiment in the short term. This could result in a slight decrease in stock price as the market adjusts to the new information.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100